KURA Stock Analysis: Buy, Sell, or Hold?
KURA - Kura Oncology, Inc.
$8.12
-0.10 (-1.22%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When KURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called KURA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KURA is currently trading at $8.12, which is considered oversold relative to its 30-day fair value range of $8.77 to $10.44.
Technical Outlook: Technically, KURA is in a uptrend. The price is currently testing key support at $8.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KURA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $32.55 (+295.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KURA is in a uptrend. The price is currently testing key support at $8.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KURA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $32.55 (+295.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$8.77 -
$10.44
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding KURA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 295.9% below Wall St target ($32.55)
- CAUTION: 5-day price weakness (-5.9%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$8.77 -
$10.44
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$8.02
Resistance Level
$9.18
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.16
Wall Street Target
$32.55
(+295.9%)
Profit Margin
-208.5%
Last updated: January 31, 2026 1:04 AM ET
Data refreshes hourly during market hours. Next update: 2:04 AM
Data refreshes hourly during market hours. Next update: 2:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KURA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian T Powl
SELL
8891 shares
2025-09-29
Kathleen Ford
SELL
6892 shares
2025-09-29
Mollie Leoni
SELL
12314 shares
2025-09-29
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced KURA Option Strategies
Professional options setups generated by AI based on today's KURA price and gamma walls.
